March 7, 2002
MDL Information Systems Inc.
President and CEO
MDL Pioneers Use of Graphical Databases
What is the history of your organization’s involvement in life sciences?
Rougeau: MDL Information Systems was launched as a computer-aided drug design firm (then known as Molecular Design Limited) in the late 1970s. The company’s first product, a first-of-its-kind system for storing and retrieving molecules as graphical structures, revolutionized the way scientists accessed and managed chemical information. Today MDL is the world’s largest discovery informatics company. Our solutions let scientists capture, manage, integrate, share, and interpret data while simultaneously assimilating it into efficient workflows to accelerate the discovery process.
What is your vision for the development of the life sciences market?
Rougeau: Science and informatics competencies are both necessary components in the discovery of new drugs. In fact, in today’s drug discovery companies, the informatics infrastructure is a key competitive differentiator. MDL’s installed base in the pharmaceutical and biotechnology sectors is almost universal. This means we’re uniquely positioned to help our customers implement cost-effective, integrated informatics and experiment management systems that enable breakthrough results. My vision is for MDL to play a key role in unleashing the potential power of informatics in discovery research by continuing to bring information and life sciences researchers together in innovative and effective ways.
What products and services does your company provide to the life sciences market?
Rougeau: MDL is supporting the life sciences with a wide range of information- and experiment-management software applications, content products, and services. For example, MDL reference databases in chemistry and new materials discovery, including Crossfire Beilstein and Gmelin, provide the industry’s most comprehensive collection of information about compounds and reactions. MDL’s ISIS (Integrated Scientific Information System) is the industry standard in the chemical and life sciences industries. If a pharmaceutical company works with small molecule chemistry, it is virtually a certainty, with few exceptions, that they use ISIS to manage, search, and register this crucial data. MDL’s Assay Explorer® enables scientists to register, access, and analyze data from biological assays, while ApexTM tracks plate locations, contents, and histories. Integrated information- and experiment-management solutions like these are helping life sciences organizations accelerate the pace of discovery research—saving time, money, and experimental resources in the process.
What new products and services do you have in development?
Rougeau: In 2002 MDL is launching innovative discovery informatics and decision support solutions that will help scientists make better decisions more quickly—improving the productivity of drug discovery. Our integrated solutions will be based on isentris™, a common architectural framework for managing life sciences information that exploits non-proprietary, industry-standard technologies. MDL’s isentris will extend the discovery domain by deploying robust, standard informatics systems to researchers while controlling the costs of custom development.
Return to main index page.